Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BRTX will decline by -100.00% over the next 2 Weeks and hit $0.00 by Tuesday, March 10, 2026. In that time frame, BRTX's share price is expected to range between $0.00 and $0.15.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 11, 2026 | 0.00 | 0.00 | 0.17 |
| Mar 10, 2026 | 0.00 | 0.00 | 0.19 |
| Mar 9, 2026 | 0.00 | 0.11 | 0.35 |
| Mar 6, 2026 | 0.00 | 0.05 | 0.30 |
| Mar 5, 2026 | 0.00 | 0.04 | 0.30 |
| Mar 4, 2026 | 0.00 | 0.07 | 0.32 |
| Mar 3, 2026 | 0.00 | 0.11 | 0.35 |
| Mar 2, 2026 | 0.00 | 0.26 | 0.50 |
| Feb 27, 2026 | 0.00 | 0.21 | 0.46 |
| Feb 26, 2026 | 0.00 | 0.20 | 0.43 |
BRTX shares fell -16.47% in Wednesday, February 25, 2026's trading session, dropping from a previous close of $0.27 to move at $0.23. The stock demonstrated notable intraday movement (see BRTX's key stats for a full breakdown), fluctuating between $0.21 and $0.26, a +21.10% trading range. While recent weeks have seen some volatility, BRTX has managed to secure a -45.44% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 13.66M shares changing hands, 202.47M fewer than the previous session. This amounted to $3.08M in total market activity.
Will BRTX Continue Its Downward Trend?
According to analyst ratings and projections for BRTX, BioRestorative Therapies, Inc. shares are anticipated to decrease by -36.25%, potentially reaching $0.17 per share by March 11, 2026. Short-term technical indicators for BRTX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the BRTX stock forecast, now is not the best time to buy BRTX stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on BRTX covering social and institutional perspectives.
BRTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BRTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 19.94% to 21.70%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 30.46%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 38.12%, signals a bearish bias in the long-term trend. Insights into BRTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BioRestorative Therapies Short-Term Forecasts
BRTX Forecast For Next 5 Days
Our algorithm anticipates BioRestorative Therapies (BRTX) stock could hit $0.07 by Mar 04, 2026. This represents a -69.35% fall from today's price, following a -5.27% change over the past five days.
BRTX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for BioRestorative Therapies, Inc. (BRTX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.04, which would mean a -82.23% decrease from the current price of $0.23. Projections for this period range from a high of $0.35 to a low of $0.00.
BRTX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for BioRestorative Therapies's price over the next three months point to a rise. BRTX stock is expected to peak at $1.70 on May 11, 2026 after potentially dipping to $0.36 on Mar 17, 2026. On average, BRTX is likely to trade around $1.03 in the coming 90 days.
BioRestorative Therapies Stock Forecast 2025
Based on our predictive models, BioRestorative Therapies (BRTX) is expected to trade between $0.00 and $1.79 throughout 2026. This would result in an average price of $1.13, potentially offering investors a +402.00% return from current levels.
BioRestorative Therapies, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, BioRestorative Therapies, Inc. (BRTX) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.80 and $0.99, settling at an average of $0.89. This could translate to a +295.38% gain.
March 2026
Based on current market signals, BioRestorative Therapies, Inc. is projected to trend march 2026. We forecast a trading range from $0.36 to $0.90, with a likely average price of $0.68. Investors could expect a potential return of +202.09%.
April 2026
Our predictive algorithms indicate BioRestorative Therapies, Inc. stock may see a shift in April 2026. The expected range spans $0.70–$1.34, with an average target of $1.04. This represents a positive outlook and a possible gain of +362.02%.
May 2026
Analyzing established trends, BioRestorative Therapies, Inc. looks set to move in May 2026. Projections place the stock between $1.01 and $1.70, averaging around $1.43. This suggests a +535.27% gain from current levels.
June 2026
Market indicators suggest BioRestorative Therapies, Inc. could experience notable changes during June 2026. Prices could fluctuate within $0.99 to $1.79, with a midpoint forecast of $1.48. The stock might deliver a +557.49% gain.
July 2026
Forecasting for July 2026, models estimate that BioRestorative Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.50 and $1.49, averaging $1.16. This signals a positive trajectory with potential returns around +415.33%.
August 2026
According to our latest forecast models, BioRestorative Therapies, Inc. (BRTX) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.37 and $1.14, settling at an average of $1.12. This could translate to a +397.56% gain.
September 2026
Based on current market signals, BioRestorative Therapies, Inc. is projected to trend september 2026. We forecast a trading range from $0.00 to $1.15, with a likely average price of $1.27. Investors could expect a potential return of +464.19%.
October 2026
Our predictive algorithms indicate BioRestorative Therapies, Inc. stock may see a shift in October 2026. The expected range spans $0.00–$1.22, with an average target of $1.39. This represents a positive outlook and a possible gain of +517.50%.
November 2026
Analyzing established trends, BioRestorative Therapies, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $0.63, averaging around $0.92. This suggests a +308.71% gain from current levels.
December 2026
Market indicators suggest BioRestorative Therapies, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $0.49, with a midpoint forecast of $0.85. The stock might deliver a +277.61% gain.
January 2027
Forecasting for January 2027, models estimate that BioRestorative Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.19, averaging $0.66. This signals a positive trajectory with potential returns around +193.20%.
February 2027
According to our latest forecast models, BioRestorative Therapies, Inc. (BRTX) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $0.11, settling at an average of $0.67. This could translate to a +197.65% gain.
BRTX's history of dividends and stock splits also plays a role in long-term investor confidence.